chemotherapy
Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.
Lung Cancer Study Reveals Tumor Microenvironment Role in Neoadjuvant Treatment Resistance
Researchers used single-cell and spatial transcriptomics to find immune cell interactions linked to neoadjuvant immunotherapy-chemotherapy response in non-small cell lung cancer.
Foresight Diagnostics Launches Lymphoma Personalized Treatment Clinical Trial
The trial will study the use of Foresight's Clarity MRD assay in identifying early treatment responders for therapy de-escalation.
Investigators from Atrium Health recently published a study comparing pretreatment and posttreatment testing, showing a strong benefit in a real-world clinical cohort.
Polygenic Score May Help Personalize Induction Chemo, Improve Black Pediatric AML Patients' Outcomes
At ASH, researchers reported that a PGx-based score could identify the cytarabine-based induction therapy young Black patients are most likely to benefit from.